ArticlePhenomics (Cham, Switzerland)2022

Recent Advances in Understanding of Alzheimer's Disease Progression through Mass Spectrometry-Based Metabolomics.

Jericha Mill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.